NEW YORK (GenomeWeb News) — Panagene has licensed PNA monomers from the Copenhagen Inventor Group that allows Panagene to synthesize, make, and sell peptide nucleic acids, the company said Tuesday.
The South Korean company adds this license agreement to a previous one with CIG for patents for PNA custom synthesis.
Panagene estimated that it is currently around 5 percent of the DNA/RNA synthesis market and said the new license will enable it to increase this share “significantly.”

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.